<PAGE>
---------------------------
OMB Number: 3235-0145
Expires: December 31, 1997
Estimated average burden
hours per response 14.90
---------------------------
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
SCHEDULE 13G
UNDER THE SECURITIES EXCHANGE ACT OF 1934
(AMENDMENT NO. ONE)*
Cardiac Pathways Corporation
- --------------------------------------------------------------------------------
(NAME OF ISSUER)
Common Stock, $0.001 par value per share
- --------------------------------------------------------------------------------
(TITLE OF CLASS OF SECURITIES)
141408 10 4
- --------------------------------------------------------------------------------
(CUSIP NUMBER)
*The remainder of this cover page shall be filled out for a reporting person's
initial filing of this form with respect to the subject class of securities, and
for any subsequent amendment containing information which would alter the
disclosures provided in a prior cover page.
The information required in the remainder of this cover page shall not be deemed
to be "filed" for the purpose of Section 18 of the Securities Exchange Act of
1934 ("Act") or otherwise subject to the liabilities of that section of the Act
but shall be subject to all other provisions of the Act (however, see the
Notes).
SEC 1745 (2-95)
Page 1 of 5 Pages
<PAGE>
- ----------------------- -------------------
CUSIP NO. 141408 10 4 13G PAGE 2 OF 5 PAGES
- ----------------------- -------------------
- --------------------------------------------------------------------------------
1 NAME OF REPORTING PERSON
S.S. OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSON
Mir A. Imran ###-##-####
- --------------------------------------------------------------------------------
2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP*
(a) [_]
(b) [_]
- --------------------------------------------------------------------------------
3 SEC USE ONLY
- --------------------------------------------------------------------------------
4 CITIZENSHIP OR PLACE OF ORGANIZATION
U.S.A.
- --------------------------------------------------------------------------------
5 SOLE VOTING POWER
NUMBER OF 414,500
SHARES ----------------------------------------------------------------
BENEFICIALLY 6 SHARED VOTING POWER
OWNED BY
EACH 0
REPORTING ----------------------------------------------------------------
PERSON WITH 7 SOLE DISPOSITIVE POWER
414,500
----------------------------------------------------------------
8 SHARED DISPOSITIVE POWER
0
- --------------------------------------------------------------------------------
9 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
414,500
- --------------------------------------------------------------------------------
10 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES
CERTAIN SHARES*
Not Applicable
- --------------------------------------------------------------------------------
11 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9
4.3% (based on 9,580,728 shares of Common Stock outstanding as of
December 31, 1997
- --------------------------------------------------------------------------------
12 TYPE OF REPORTING PERSON*
IN
- --------------------------------------------------------------------------------
<PAGE>
CUSIP No. 141408 10 4 Page 3 of 5 Pages
------------
*SEE INSTRUCTION BEFORE FILLING OUT
ITEM 1.
(a) Name of Issuer Cardiac Pathways Corporation
(b) Address of Issuer's Principal Executive Offices
995 Benecia Avenue, Sunnyvale, CA 94086
ITEM 2.
(a) Name of Person Filing Mir A. Imran
(b) Address of Principal Business Office or, if none, Residence
26641 Laurel Lane, Los Altos, CA 94022
(c) Citizenship United States
(d) Title of Class of Securities Common Stock, $0.001 par value
per share
(e) CUSIP Number 141408 10 4
ITEM 3. IF THIS STATEMENT IS FILED PURSUANT TO RULE 13d-1(b), OR 13d-2(b), CHECK
WHETHER THE PERSON IS A:
(a) [_] Broker or Dealer registered under Section 15 of the Act
(b) [_] Bank as defined in section 3(a)(6) of the Act
(c) [_] Insurance Company as defined in section 3(a)(19) of the Act
(d) [_] Investment Company registered under section 8 of the Investment
Company Act
(e) [_] Investment Adviser registered under section 203 of the
Investment Advisers Act of 1940
(f) [_] Employee Benefit Plan, Pension Fund which is subject to the
provisions of Employee Retirement Income Security Act of 1974 or
Endowment Fund, see (S)240.13d-1(b)(1)(ii)(F)
(g) [_] Parent Holding Company, in accordance with (S)240.13d-
1(b)(ii)(G) (Note: See Item 7)
(h) [_] Group, in accordance with (S)240.13d-1(b)(1)(ii)(H)
<PAGE>
CUSIP No. 141408 10 4 Page 4 of 5 Pages
------------
N/A -- The reporting person acquired all its shares prior to the registration of
the Issuer's shares pursuant to Section 12 of the Securities Exchange Act of
1934, as amended; therefore, this filing is pursuant to Rule 13d-1(c).
ITEM 4. OWNERSHIP
(a) Amount Beneficially Owned
(b) Percent of Class
(c) Number of shares as to which such person has:
(i) sole power to vote or to direct the vote
(ii) shared power to vote or to direct the vote
(iii) sole power to dispose or direct the disposition of
(iv) shared power to dispose or direct the disposition of
ITEM 5. OWNERSHIP OF FIVE PERCENT OR LESS OF A CLASS
If this statement is being filed to report the fact that as of the date
hereof the reporting person has ceased to be the beneficial owner of more that
five percent of the class of securities, check the following [X].
ITEM 6. OWNERSHIP OF MORE THAN FIVE PERCENT ON BEHALF OF ANOTHER PERSON.
Not Applicable
ITEM 7. IDENTIFICATION AND CLASSIFICATION OF THE SUBSIDIARY WHICH ACQUIRED THE
SECURITY BEING REPORTED ON BY THE PARENT HOLDING COMPANY.
Not Applicable
ITEM 8. IDENTIFICATION AND CLASSIFICATION OF MEMBERS OF THE GROUP
Not Applicable
ITEM 9. NOTICE OF DISSOLUTION OF GROUP
Not Applicable
<PAGE>
CUSIP No. 141408 10 4 Page 5 of 5 Pages
------------
ITEM 10.
By signing below I certify that, to the best of my knowledge and belief,
the securities referred to above were acquired in the ordinary course of
business and were not acquired for the purpose of and do not have the effect of
changing or influencing the control of the issuer of such securities and were
not acquired in connection with or as a participant in any transaction having
such purposes or effect.
SIGNATURE
After reasonable inquiry and to the best of my knowledge and belief, I
certify that the information set forth in this statement is true, complete and
correct.
February 18, 1998
--------------------------------------
Date
/s/ Garrett C. McGonigal
--------------------------------------
Signature
Garrett C. McGonigal, Attorney-in-Fact
--------------------------------------
Name/Title
